Penn Medicine Abramson Cancer Center


 

ASH 2019 Update on Promising New Agents in R/R Multiple Myeloma: Iberdomide, TAK573, Tasquinimod & Choosing Therapies with Limited Data

19 views
February 24, 2020
Comments 0
Login to view comments. Click here to Login